Status:
COMPLETED
A Study of IMC-1 In Patients With Fibromyalgia
Lead Sponsor:
Innovative Med Concepts, LLC
Conditions:
Fibromyalgia
Chronic Pain
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
This is a randomized, double-blind, placebo-controlled, 16-week study designed to evaluate the hypothesis that tissue-resident herpes virus may be causally related to fibromyalgia symptoms or recurren...
Eligibility Criteria
Inclusion
- Diagnosis of fibromyalgia
- English speaker
Exclusion
- Rheumatologic diseases
- Bipolar disease, OCD, severe anxiety, schizophrenia
- Systemic infection, severe cardiac disease, chronic steroid usage
- chronic opioid usage
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT01850420
Start Date
May 1 2013
End Date
March 1 2014
Last Update
March 27 2015
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
IMC Study Site
Birmingham, Alabama, United States
2
IMC Study Site
Sacramento, California, United States
3
IMC Study Site
San Diego, California, United States
4
IMC Study Site
Vista, California, United States